Formycon AG logo

Formycon AG

FSX:FYB.DE

Overview | Financials
Company Name Formycon AG
Symbol FYB.DE
Currency EUR
Price 50
Market Cap 882,845,000
Dividend Yield 0%
52-week-range 37.65 - 67.8
Industry Biotechnology
Sector Healthcare
CEO Dr. Stefan Glombitza
Website https://www.formycon.com

An error occurred while fetching data.

About Formycon AG

Formycon AG develops and markets biosimilar products. Its product pipeline includes FYB201, a biosimilar candidate for Lucentis, an ophthalmic drug used in the treatment of neovascular age-related macular degeneration and other serious eye diseases; FYB202, a biosimilar candidate for Stelara, a biopharmaceutical used in the treatment of inflammatory diseases, such

Related Stocks

NextGen Healthcare, Inc. logo

NextGen Healthcare, Inc.

QY1.F

22.4 EUR

RHÖN-KLINIKUM Aktiengesellschaft logo

RHÖN-KLINIKUM Aktiengesellschaft

RHK.DE

11.7 EUR

Stratec SE logo

Stratec SE

SBS.DE

40 EUR

Nexus AG logo

Nexus AG

NXU.DE

47.85 EUR

Drägerwerk AG & Co. KGaA logo

Drägerwerk AG & Co. KGaA

DRW8.DE

42 EUR

Eckert & Ziegler Strahlen- und Medizintechnik AG logo

Eckert & Ziegler Strahlen- und Medizintechnik AG

EUZ.DE

40.56 EUR

MorphoSys AG logo

MorphoSys AG

MOR.DE

27.3 EUR

Biotest Aktiengesellschaft logo

Biotest Aktiengesellschaft

BIO3.DE

27.1 EUR

Financials

Numbers are in millions USD

Numbers are in millions USD